Welcome!
Singapore Institute of Advanced Medicine Holdings (SAM Holdings)
Results
Singapore Institute of Advanced Medicine Holdings reports FY2024 loss of $37.4 mil
SAM’s 2HFY2024 loss also deepened by 75% y-o-y to $16.2 million compared to $9.3 million in 2HFY2023.
29 days ago
Company in the news
Singapore Institute of Advanced Medicine Holdings to release its results by Oct 29
On Aug 16, the group filed an application for the extension to the SGX RegCo.
September 18, 2024
Results
Singapore Institute of Advanced Medicine Holdings to report ‘significant’ net loss after tax for FY2024
The company is expected to release its results on or before Aug 29.
July 31, 2024
Deals, joint ventures & alliances
SAM Holdings partners with Australia-based EnGeneIC to bring latest cancer treatment innovation to Singapore
SAM Holdings will collaborate with EnGeneIC on a profit-sharing basis.
June 10, 2024
IPO
Singapore Institute of Advanced Medicine Holdings aims to list on Catalist to better help cancer patients
SAM Holdings raises funds via Catalist IPO to improve cancer treatment options in Singapore.
February 08, 2024
IPO
Singapore Institute of Advanced Medicine Holdings to IPO on Catalist Board at 23 cents per share
Singapore Institute of Advanced Medicine Holdings to list on Catalist Board of SGX. IPO price at 23 cents per share.
February 03, 2024